Vestal Point Capital, LP - 31 Mar 2025 SCHEDULE 13G Report for Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH)

Filing Manager
Vestal Point Capital, LP
Reporting Manager
Vestal Point Capital, LP
Security
Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share
Symbol
DNTH
Shares outstanding
32,076,774 shares
Disclosed Ownership
1,700,069 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 16:14:25 UTC
Date of event
31 Mar 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vestal Point Capital, LP 5.3% 1,700,069 0 1,700,069 /s/ Ryan Wilder By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder 5.3% 1,700,069 0 1,700,069 /s/ Ryan Wilder Ryan Wilder, Individually